Trial Profile
A prospective trial to evaluate the efficacy and safety of lower dose Grazoprevir (MK-5172) and Ribavirin in patients with hepatitis C virus genotype 1 infection.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Grazoprevir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 14 Dec 2015 New trial record